Company News
Veerhealth Care USFDA Approval Fuels 92% FY26 Revenue Growth
Veerhealth Care submitted an investor presentation disclosing its rare USFDA approval for OTC drug exports in June 2025, a significant regulatory milestone.
FY26 revenue surged 92% YoY to ₹32.48 crore
